comparemela.com

Latest Breaking News On - மனம் குணப்படுத்த - Page 6 : comparemela.com

Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing

Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing PALM BEACH, Fla., Jan. 12, 2021 /PRNewswire/ After being relegated to the margins of sincere scientific examination for about five decades, growing researchers and scientists are exploring the therapeutic value of psychedelic drugs and compounds that could be a new treatment option for people with depression. According to Data Bridge Market Research North America psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Data Bridge added: Psychedelic drugs are the category of therapeutic pha

Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research

Mind Cure iSTRYM (CNW Group/Mind Cure Health Inc.) As a life sciences and digital therapeutics company, providing speed to market with novel psychedelic therapies through deeper data analytics is a strength we are developing with iSTRYM. Further, as we build out our database for mental wellness, both therapists and individuals will get mental wellness protocols for wellness optimization and support. iSTRYM exists to become the source that individuals turn to for science-backed, personalized mental health support at scale. - Kelsey Ramsden, President & CEO.  Gaps between clients, researchers, and therapists create disparities in the collection of critical insights that arise outside of psychedelic-assisted therapy sessions, and ultimately prevent new scientific breakthroughs. Mind Cure s

Mind Cure releases mental health digital therapeutic for psychedelic research

Share Mind Cure, a Canadian mental health company, has released a digital therapeutic tool designed to close the gaps between patients, clinicians and researchers. Called iSTRYM, the app provides close to real-time data regarding patient care, procedures and protocols. It’s described as a centralized management system that can be used for a variety of mental health treatments, including those in psychedelic therapeutic research. iSTRYM works by gathering data that arise outside of psychedelic-assisted therapy sessions, such as weather, location, mood or heart rate. With the help of artificial intelligence, the app generates insights found across the datasets to guide clinicians towards well-rounded diagnoses, treatments and personalized care experiences.

Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club

Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club News provided by Share this article Share this article Mind Cure s nootropic products are set to launch across 17 locations within North America starting Feb, 2021. VANCOUVER, BC, Dec. 31, 2020 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( Mind Cure or the Company ) is pleased to announce that Mind Cure s three nootropic supplements, Focus, Energy, and Immunity, will be available in Body Energy Club locations to provide customers with a tactile, in-store shopping experience. Body Energy Club carries one of the widest varieties of high-quality supplements for individuals seeking to achieve peak performance.

Mind Cure Announces Novel Supplement Product to Address Teen Wellness

Mind Cure Announces Novel Supplement Product to Address Teen Wellness News provided by Share this article Share this article Mind Cure announces all-natural supplement designed to relieve restlessness and nervousness in teens, to be released in early 2021 VANCOUVER, BC, Dec. 29, 2020 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( Mind Cure or the Company ) is pleased to announce the release of its latest formulation, Mind Cure Teen, an all-natural supplement designed specifically to relieve nervousness, restlessness, and sleeplessness caused by mental stress in teens. Mind Cure has teamed with high-calibre formulators to broaden the impact and scalability of mental health remediation. The Company s current release will involve a North America-wide distribution of the teen formula available for pre-order on the

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.